Malaria is a mosquito-borne disease caused by a parasite called Plasmodium - when infected mosquitoes bite the human body, the parasites multiply in the liver, and then infect red blood cells. Even though this potentially fatal disease can be prevented and cured, each year 350-500 million cases of malaria still occur worldwide, and over one million people die, most of them young children in Africa south of the Sahara, where one in every five (20%) childhood deaths is due to the effects of the disease.
Malaria is so common in Africa because a lack of resources and political instability have prevented the building of solid malaria control programs. Experts say an African child has on average between 1.6 and 5.4 episodes of malaria fever each year and according to the World Health Organization (WHO) as many as half of the world's population are at risk of malaria mainly in the world's poorest and most vulnerable countries and every 30 seconds a child dies from malaria.
According to psychologists, in addition to our physiological immune system, we also have a behavioral one: an unconscious code of conduct that helps us stay disease-free, including fear and avoidance of unfamiliar - and so possibly infected - people.
Scientists created an organoid biobank to investigate the genes that are vital for the spreading of a SARS-CoV-2 infection.
Recent research detailing mosquito immune cells provides insights into the insect immune system and how mosquitoes transmit parasites that result in malaria.
Scientists developed a new open-access database with information on drug candidates and the process of metabolization of the drugs by the body.
In our latest interview, AZoLifeSciences spoke to a team of researchers about their latest research which involved carrying out CRISPR/Cas9 in Space.
A new technique for obtaining pure malaria parasites from infected mosquitos could speed up the development of novel, more powerful malaria vaccinations.
Using cutting-edge video microscopy, researchers have successfully observed the molecular intricacies of how malaria parasites enter red blood cells.
CRISPR-based technologies offer enormous potential to benefit human health and safety, from disease eradication to fortified food supplies. As one example, CRISPR-based gene drives, which are engineered to spread specific traits through targeted populations, are being developed to stop the transmission of devastating diseases such as malaria and dengue fever.
Climate change will make outbreaks of West Nile virus more likely in the UK within the next 20-30 years, scientists say. West Nile virus is spread by mosquitoes and has no vaccine. Most people have no symptoms, but it can cause serious neurological disease.
Since the onset of the CRISPR genetic editing revolution, scientists have been working to leverage the technology in the development of gene drives that target pathogen-spreading mosquitoes such as Anopheles and Aedes species, which spread malaria, dengue and other life-threatening diseases.
Researchers at the Francis Crick Institute and the Latvian Institute of Organic Synthesis have designed a drug-like compound which effectively blocks a critical step in the malaria parasite life cycle and are working to develop this compound into a potential first of its kind malaria treatment.
In celebration of National DNA Day, AZoLifeSciences interviews renowned DNA expert Professor George Church about his life-long career in DNA research.
Scientists from the University of Basel have gained insights into the specialization of T cells.
The slowdown in global warming that was observed at the end of last century was reflected by a decrease in malaria transmission in the Ethiopian highlands, according to a study led by the Barcelona Institute for Global Health, an institution supported by "la Caixa" Foundation, and the University of Chicago.
Robust new genetic engineering techniques have given researchers the ability to transform many sectors of global urgency.
A new software tool allows researchers to quickly query datasets generated from single-cell sequencing. Users can identify which cell types any combination of genes are active in.
Everyone knows 2 + 2 = 4, but what about mosquitoes plus malaria? Lauren Childs, an assistant professor in the Department of Mathematics at Virginia Tech, says there's an equation for that too.
A global team of researchers has developed a new strategy for fast and reliable antibody tests, which can quantify the immune response induced by vaccination and reveal the timeline and stage of pathogen infection.
An inexpensive, long-lasting and easy-to-administer vaccine against malaria could be a game-changer for millions of people living in countries where the mosquito-borne disease is endemic.
To control mosquito populations and prevent them from transmitting diseases such as malaria, many researchers are pursuing strategies in mosquito genetic engineering. A new Texas A&M AgriLife Research project aims to enable temporary "test runs" of proposed genetic changes in mosquitoes, after which the changes remove themselves from the mosquitoes' genetic code.